Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The term "porokeratotic adnexal ostial nevus" is proposed to unify overlapping skin conditions involving eccrine and hair follicles.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Early diagnosis and haemodialysis can effectively treat thallium poisoning.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

PCOS is often caused by hormonal imbalances that can lead to various health issues and may indicate a risk for future metabolic and cardiovascular problems.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

The study found an efficient method to extract antioxidants from Hibiscus leaves.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Hydroxychloroquine may help delay skin damage in lupus patients.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

AGD1 is important for root hair development in Arabidopsis, working with phosphoinositide signaling and the actin cytoskeleton.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

PRP injections may improve hair thickness and density in female hair loss patients.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.